The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Ruben Mesa, MD: Ruxolitinib as a Myelofibrosis Treatment
Ruben Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, discusses treating myelofibrosis with ruxolitinib therapy.
Ruben Mesa, MD: Myelofibrosis Patients Frequently Present Symptoms
Ruben Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, discusses the visible symptoms and diagnosis process for patients with myelofibrosis.
Naveen Pemmaraju, MD: Tagraxofusp for BPDCN
New trial results show the cytotoxin delivers clinical responses in patients with untreated or relapsed forms of the rare disease.
Naveen Pemmaraju, MD: Managing Anemia with Ruxolitinib Care
The common, concerning adverse effect requires a careful eye from clinicians and new therapy options.
New Therapy on Horizon for Rare Lung Cancer Subtype
MET inhibitor capmatinib may hold promise for a small subtype of patients with a non-small cell lung cancer, according to new ASCO 2019 findings.
Naveen Pammaraju, MD: Primary Care & JAK1 Inhibitors in Myelofibrosis
Patients with the rare cancer condition requires both a collaborative physician network and proven therapies.
Investigational Isatuximab Shows Added Benefit for Multiple Myeloma
New phase 3 trial results show the monoclonal antibody plus pomalidomide and dexamethasone improves progression free survival and overall response rate among patients with RRMM.
New Immunotherapy Blocks Key Macrophage Checkpoint in AML Care
Hu5F9-G4, aided by azacytidine, showed the potential to remove signals on cancer cells that would normally prevent a patient’s body from eliminating said cells.
Subcutaneous Daratumumab Non-Inferior, Less Burdensome than IV Regimen
Phase 3 results show the therapy plus recombinant human hyaluronidase is comparably safe and effective for patients with relapsed-refractory multiple myeloma.
Primary Care Physicians Hold Significant Value in Oncology Care
A discussion held at ASCO 2019 highlighted the statistical value associated with primary care collaboration across specialties.
Low-Income, Female Patients Likely to Face Delayed Leukemia Diagnoses
New analysis shows patients from either of these populations often take longer to be diagnosed with leukemia or lymphoma than their male or median-income counterparts.
Adenoid Cystic Carcinoma Does Not Vary According to Race, Gender
A new study shows a profound lack of genetic markers, allowing doctors to standardize treatment.
Rituximab Infusion Side Effects Abated by Rupatadine, Montelukast
A new study shows that adding this pair of drugs reduces costs and side effects while increasing efficacy.
Venetoclax with Cytarabine in Children with Relapsed or Refractory AML
Investigators from St. Jude's Children Research Hospital presented the results of the phase 1 trial at ASCO 2019 in Chicago.
VIT Improves Survival Measures in Patients with Relapsed/Refractory RMS
Investigators conducted an open-label, randomized, multi-center phase 2 study of VIT and vincristine with irinotecan without temozolomide that included 120 patients from 37 European centers.
Cost and Length of Stay in Pancreatic Cancer Patients
A study presented at ASCO 2019 examined the differences between hospitalization cost and length of stay among pancreatic cancer patients based on location of the disease.
Pulmonary Rehab Rates for African Americans Remain Low
Overall rates of pulmonary rehabilitation rose in areas with greater program density, but rates for African Americans remained low despite greater program density.
Kristin Highland, MD: Practices and Metrics for Improving Scleroderma Care
The rare disease patient population is smaller and in need of immediate treatment. What's next after the SENSCIS trial results?
Catching PAH at the Primary Care Office
The signs and symptoms of the rare, chronic condition are not consistently detected in the first line of care.
Andrew Varga, MD: How Sleep Apnea Affects Elderly Spatial Orientation
A new study from ATS showed an early symptom of Alzheimer disease is more prevalent in older patients with moderate OSA.
Lower ED Triage Scores Linked to Antibiotic Delays for Sepsis Patients
Sepsis patients with an acuity score of 3 received antibiotics half an hour later than patients with the slightly more critical score of 2.
Historical Redlining Associated with More Asthma ED Visits
Neighborhoods redlined in the 1930s continue to feel the effects of the racially discriminatory practice, including differences in asthma-related emergency visits.
Neomi Shah, MD, MPH: The Need for Patient Sleep Assessment
Sleep apnea is associated with pulmonary, cardiovascular, psychiatric, neurologic, and weight-related effects. Primary care physicians need to monitor sleep health more.
Dr. Geoff Bellingan: The Future for Multi-Stem Cell Therapy
Previous analyses into MultiStem Cell Therapy have shown benefits and safety in stroke patients. What will it take for the therapy to reach a phase 3 trial for ARDS?
Stella Lee, MD: CRSwNP Patients, Before Dupilumab
Within a week of treatment on the investigative biologic, patients with severe form of the condition were reporting a return of smell and taste.
Using All the Pathways to PAH Care
Though the prostacyclin-targeting therapy selexipag is beneficial for PAH patients, investigators advise treatment to a trio of pathways.
High Regional Primary Care Use Associated with Less Critical Illness
Increased primary care use in a region was associated with reduced rates of ICU admission and mechanical ventilation use.
Providers Split on Family Presence During ICU Procedures
While 35% of providers say they’re unlikely to allow family to be present during ICU procedures, the 38% who say it’s a regular practice overwhelmingly call it a positive experience.
Neomi Shah, MD, MPH: Cardiovascular Risk Concerns in Sleep Apnea
Why are major adverse cardiovascular events not treated as the concern risk factors they are in patients with obstructive sleep apnea?
Reena Mehra, MD, MS: ADHERE Cohort Gender Findings
Upper airway stimulation, a sleep apnea treatment on the rise, is showing particular benefit for female patients.